+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Microbiome Sequencing Services Market by Service Type (16S Rrna Sequencing, Metatranscriptomic Sequencing, Shotgun Metagenomic Sequencing), Sample Type (Gut Microbiome, Oral Microbiome, Skin Microbiome), Application, End User - Global Forecast 2025-2030- Product Image
Human Microbiome Sequencing Services Market by Service Type (16S Rrna Sequencing, Metatranscriptomic Sequencing, Shotgun Metagenomic Sequencing), Sample Type (Gut Microbiome, Oral Microbiome, Skin Microbiome), Application, End User - Global Forecast 2025-2030- Product Image
New

Human Microbiome Sequencing Services Market by Service Type (16S Rrna Sequencing, Metatranscriptomic Sequencing, Shotgun Metagenomic Sequencing), Sample Type (Gut Microbiome, Oral Microbiome, Skin Microbiome), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138548
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Illuminating the Expansive Potential and Strategic Importance of Human Microbiome Sequencing Across Diverse Biological and Clinical Domains

The human microbiome has emerged as a pivotal frontier at the intersection of life sciences, healthcare, agriculture, and biotechnology. As researchers delve deeper into the intricate relationships between microbial communities and human health, sequencing services have become indispensable tools for decoding microbial diversity. From academic laboratories deciphering fundamental host-microbe interactions to pharmaceutical companies developing next generation therapeutics, the demand for high resolution, accurate sequencing has surged. Moreover, advances in sequencing platforms have democratized access, enabling a new wave of translational studies that bridge discovery science with clinical applications.

In parallel, rising interest in personalized medicine has amplified the need for robust microbiome profiling, driving service providers to innovate in sample processing, data interpretation, and bioinformatics pipelines. Consequently, the market is witnessing a dynamic convergence of methodological breakthroughs, evolving regulatory frameworks, and strategic partnerships aimed at unlocking the microbiome’s full potential. This executive summary offers a concise yet comprehensive introduction to the sector’s current state, highlighting core drivers, emerging technologies, and critical challenges that define the human microbiome sequencing services landscape.

Identifying the Key Disruptive Technological and Regulatory Shifts Redefining the Human Microbiome Sequencing Service Landscape Globally

The human microbiome sequencing sector is undergoing transformative shifts driven by novel technological innovations and evolving regulatory landscapes. On one hand, the introduction of long read sequencing technologies has redefined resolution capabilities, enabling unprecedented insights into microbial genomes, structural variants, and functional dynamics. Meanwhile, cloud-based bioinformatics platforms, powered by artificial intelligence, have streamlined data processing while enhancing interpretability through advanced pattern recognition algorithms. These converging developments have reduced turnaround times and cost per sample, catalyzing new research studies and accelerating time to market for therapeutics.

Concurrently, global regulatory agencies have instituted more rigorous guidelines for microbiome-based diagnostics and data privacy, prompting providers to fortify quality management and compliance systems. The pandemic underscored the critical role of microbiome research in understanding host responses, thus increasing governmental funding and cross-sector collaborations. This interplay of technological agility and stringent oversight is reshaping service portfolios, compelling providers to innovate rapidly while ensuring transparency and reproducibility. As a result, the sector is evolving from fragmented offerings toward integrated end-to-end solutions that combine sequencing, analytics, and clinical reporting.

Assessing the Multifaceted Impact of New United States Tariff Measures on Human Microbiome Sequencing Service Cost Structures And Supply Chains in 2025

In 2025, newly enacted United States tariffs have introduced multifaceted challenges for providers of human microbiome sequencing services. Increased duties on imported reagents, sequencing consumables, and laboratory instrumentation have amplified operational costs, particularly affecting smaller service laboratories that rely on global supply chains for specialized components. This cost escalation has prompted many providers to re-examine supplier agreements, negotiate long term contracts, and explore domestic manufacturing alternatives to mitigate price volatility.

Furthermore, the tariffs have led to extended lead times for critical equipment, creating backlog pressures that may delay project timelines and undermine customer satisfaction. Several industry players are therefore diversifying their sourcing strategies, collaborating with local instrument vendors, and investing in inventory buffers. At the same time, forward-thinking organizations leverage tariff exemptions and trade facilitation programs, engaging customs experts to minimize fiscal impacts. Despite these headwinds, the market’s resilience is evident in the strategic realignment toward vertically integrated workflows and enhanced supplier partnerships that collectively bolster supply chain agility and cost predictability.

Uncovering Critical Segmentation Patterns Driving Demand Dynamics Across Service Types Sample Types Applications And End Users

A nuanced analysis of service type segmentation reveals distinct trajectories across primary sequencing methodologies. The 16S rRNA approach, subdivided into Illumina, Oxford Nanopore, and PacBio platforms, remains a mainstay for bacterial community profiling, favored for its cost efficiency and established analytics frameworks. Metatranscriptomic sequencing, utilizing similar instrument breakdowns, is increasingly adopted for functional assessments of microbial gene expression, illuminating dynamic responses to environmental stimuli. Meanwhile, shotgun metagenomic sequencing, also available across the three leading platforms, has gained traction for comprehensive taxonomic and functional resolution, especially in complex sample matrices.

Sample type segmentation further delineates market opportunities, with gut microbiome analyses dominating due to their direct relevance to metabolic and gastrointestinal disorders, followed by growing interest in oral, skin, and vaginal microbiome studies, each unlocking novel diagnostic and therapeutic pathways. Application driven segmentation underscores the expanding influence of microbiome services in agricultural and animal health, clinical diagnostics, fundamental research, personalized medicine initiatives, and therapeutics development. Finally, end user profiles span academic and research institutes, clinical laboratories and hospitals, contract research organizations, and pharmaceutical and biotechnology companies, each segment presenting unique requirements for service customization, data security, and regulatory compliance.

Exploring Regional Variations And Growth Drivers Across The Americas Europe Middle East Africa And Asia Pacific In Microbiome Sequencing Services

Regional dynamics exhibit pronounced variation reflecting divergent research priorities, funding landscapes, and regulatory frameworks. In the Americas, robust government investment, coupled with a dense network of biotechnology startups and leading academic institutions, has fostered an ecosystem where microbiome sequencing services thrive. North America leads in advanced applications, while Latin American markets are emerging through collaborative public-private initiatives aimed at leveraging indigenous microbial diversity.

In the Europe, Middle East & Africa region, stringent data protection regulations and harmonized clinical standards have elevated service quality benchmarks, incentivizing providers to develop comprehensive quality assurance protocols. The region’s emphasis on personalized healthcare and translational research has created fertile ground for microbiome diagnostics, particularly within oncology and immunology sectors. Meanwhile, the Asia-Pacific market is characterized by rapid uptake in research infrastructure spending, an expanding industrial biotechnology segment, and supportive government policies promoting precision agriculture and public health genomics. Together, these regional trends underscore the importance of localized strategies, regulatory intelligence, and tailored service offerings to capture growth across diverse global markets.

Analyzing Strategic Initiatives Partnerships And R&D Investment Trends Among Leading Human Microbiome Sequencing Service Providers

Industry leaders in human microbiome sequencing services are distinguishing themselves through targeted investments, strategic partnerships, and aggressive research and development trajectories. Major sequencing platform providers are expanding their portfolio to include turnkey microbiome solutions, combining hardware, reagents, and proprietary bioinformatics tools. Simultaneously, contract research organizations are forging alliances with academic centers and clinical networks to broaden sample acquisition and data validation capabilities.

In addition, specialty bioinformatics firms are collaborating with sequencing experts to co develop machine learning algorithms that enhance taxonomic resolution and biomarker discovery. Mergers and acquisitions remain a central theme, as larger entities seek to consolidate fragmented market segments and achieve economies of scale. Meanwhile, a new breed of innovative startups is emerging, focusing on niche applications such as virome profiling, microbial metabolomics, and longitudinal microbiome monitoring. These competitive moves are reshaping the market hierarchy, compelling organizations to continually recalibrate their value propositions to maintain relevance and market leadership.

Formulating Targeted Strategic Recommendations To Enhance Competitiveness And Drive Innovation In The Evolving Human Microbiome Sequencing Market

To thrive in the evolving human microbiome sequencing landscape, industry leaders should adopt a multipronged strategic approach. Investment in automation and miniaturization of library preparation workflows can significantly reduce per sample costs while improving reproducibility. Simultaneously, integrating artificial intelligence into data analytics pipelines will augment predictive capabilities and accelerate biomarker discovery, enhancing service differentiation.

In parallel, securing resilient supply chains through diversified sourcing and localized manufacturing partnerships will mitigate exposure to trade fluctuations and regulatory shifts. Furthermore, active participation in standardization consortia and regulatory working groups can shape favorable policy developments and establish credibility in clinical applications. Finally, targeted expansion into underpenetrated sample types and emerging markets, supported by strategic alliances with agricultural, veterinary, and pharmaceutical stakeholders, will unlock new revenue streams and fortify long-term growth trajectories.

Detailing A Rigorous Multi Stage Research Methodology Combining Primary Interviews Secondary Data Analysis And Advanced Statistical Validation Techniques

This research employs a rigorous multi stage methodology designed to deliver robust and actionable insights. Initially, extensive secondary research was conducted, encompassing peer reviewed publications, conference proceedings, patent filings, and regulatory databases to map the technological and regulatory landscape. This was followed by primary interviews with key opinion leaders, including academic researchers, commercial service providers, and regulatory authorities, providing nuanced perspectives on emerging trends and market challenges.

Quantitative data collected from financial reports, procurement records, and industry surveys underwent advanced statistical validation techniques to ensure consistency and accuracy. Cross verification of qualitative inputs and quantitative findings facilitated the construction of comprehensive segmentation frameworks. Finally, scenario planning exercises and sensitivity analyses were performed to evaluate the potential impact of tariff fluctuations and technology disruptions, ensuring that the conclusions drawn are both robust and adaptable to evolving market conditions.

Synthesizing Key Findings And Strategic Imperatives To Guide Stakeholders Through The Next Frontier In Human Microbiome Sequencing Services

This executive summary has synthesized critical insights into the transformative forces shaping the human microbiome sequencing services market. From pioneering technologies and evolving regulatory requirements to the tangible effects of tariff initiatives, each component underscores the sector’s dynamic nature. The segmentation analysis highlights distinct user needs across service types, sample categories, applications, and end user profiles, while regional perspectives illuminate diverse growth drivers and competitive landscapes.

Moreover, leading companies are forging strategic alliances, accelerating R&D pipelines, and adopting integrated solution models to secure market leadership. The actionable recommendations provided herein offer a clear roadmap for investment priorities, operational resilience, and strategic partnerships. As stakeholders navigate this intricate environment, embracing agility and fostering collaboration will be paramount. The findings presented establish a solid foundation for informed decision making, enabling organizations to harness the full potential of microbiome sequencing technologies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Service Type
    • 16S Rrna Sequencing
      • Illumina Sequencing
      • Oxford Nanopore Sequencing
      • Pacbio Sequencing
    • Metatranscriptomic Sequencing
      • Illumina Sequencing
      • Oxford Nanopore Sequencing
      • Pacbio Sequencing
    • Shotgun Metagenomic Sequencing
      • Illumina Sequencing
      • Oxford Nanopore Sequencing
      • Pacbio Sequencing
  • Sample Type
    • Gut Microbiome
    • Oral Microbiome
    • Skin Microbiome
    • Vaginal Microbiome
  • Application
    • Agricultural And Animal Health
    • Diagnostics
    • Microbiome Research
    • Personalized Medicine
    • Therapeutics Development
  • End User
    • Academic And Research Institutes
    • Clinical Laboratories And Hospitals
    • Contract Research Organizations
    • Pharmaceutical And Biotechnology Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific SE
  • bioMérieux S.A.
  • Azenta, Inc.
  • Novogene Co., Ltd.
  • CosmosID, Inc.
  • Microba Life Sciences Pty Ltd

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of multiomics with microbiome sequencing for precision medicine
5.2. Rapid adoption of shotgun metagenomics in clinical microbiome diagnostics pipelines
5.3. Growth of AI powered bioinformatics platforms for advanced microbiome data interpretation
5.4. Personalized probiotic and microbial therapeutic development based on sequencing insights
5.5. Expansion of direct to consumer microbiome testing services with personalized health recommendations
5.6. Increasing regulatory frameworks shaping microbiome based diagnostic and therapeutic validation
5.7. Emerging long read sequencing technologies enabling complete microbial genome assembly
5.8. Growing research focus on gut brain axis interactions driving microbiome sequencing demand
5.9. Development of microbiome based biomarkers for early disease detection and monitoring
5.10. Strategic collaborations between sequencing providers and pharma companies for microbiome drug discovery
5.11. Innovations in noninvasive sample collection devices to preserve microbial DNA integrity
5.12. Standardization and expansion of reference databases enhancing cross study microbiome comparability
5.13. Rising demand for cost effective high throughput sequencing in large scale cohort studies
5.14. Integrated host genomic and immune profiling with microbiome sequencing for holistic diagnostics
5.15. Expansion of skin and vaginal microbiome sequencing offerings for personalized dermatology and women’s health
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Microbiome Sequencing Services Market, by Service Type
8.1. Introduction
8.2. 16S Rrna Sequencing
8.2.1. Illumina Sequencing
8.2.2. Oxford Nanopore Sequencing
8.2.3. Pacbio Sequencing
8.3. Metatranscriptomic Sequencing
8.3.1. Illumina Sequencing
8.3.2. Oxford Nanopore Sequencing
8.3.3. Pacbio Sequencing
8.4. Shotgun Metagenomic Sequencing
8.4.1. Illumina Sequencing
8.4.2. Oxford Nanopore Sequencing
8.4.3. Pacbio Sequencing
9. Human Microbiome Sequencing Services Market, by Sample Type
9.1. Introduction
9.2. Gut Microbiome
9.3. Oral Microbiome
9.4. Skin Microbiome
9.5. Vaginal Microbiome
10. Human Microbiome Sequencing Services Market, by Application
10.1. Introduction
10.2. Agricultural And Animal Health
10.3. Diagnostics
10.4. Microbiome Research
10.5. Personalized Medicine
10.6. Therapeutics Development
11. Human Microbiome Sequencing Services Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Clinical Laboratories And Hospitals
11.4. Contract Research Organizations
11.5. Pharmaceutical And Biotechnology Companies
12. Americas Human Microbiome Sequencing Services Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Human Microbiome Sequencing Services Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Human Microbiome Sequencing Services Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Illumina, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. QIAGEN N.V.
15.3.4. BGI Genomics Co., Ltd.
15.3.5. Eurofins Scientific SE
15.3.6. bioMérieux S.A.
15.3.7. Azenta, Inc.
15.3.8. Novogene Co., Ltd.
15.3.9. CosmosID, Inc.
15.3.10. Microba Life Sciences Pty Ltd
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. HUMAN MICROBIOME SEQUENCING SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HUMAN MICROBIOME SEQUENCING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HUMAN MICROBIOME SEQUENCING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HUMAN MICROBIOME SEQUENCING SERVICES MARKET: RESEARCHAI
FIGURE 24. HUMAN MICROBIOME SEQUENCING SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. HUMAN MICROBIOME SEQUENCING SERVICES MARKET: RESEARCHCONTACTS
FIGURE 26. HUMAN MICROBIOME SEQUENCING SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN MICROBIOME SEQUENCING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ILLUMINA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY OXFORD NANOPORE SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PACBIO SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GUT MICROBIOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GUT MICROBIOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL MICROBIOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL MICROBIOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN MICROBIOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN MICROBIOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY VAGINAL MICROBIOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY VAGINAL MICROBIOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL AND ANIMAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL AND ANIMAL HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL LABORATORIES AND HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL LABORATORIES AND HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 108. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 109. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 110. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 111. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 112. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 113. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 122. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 123. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 126. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 127. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 192. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 193. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 194. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 195. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 196. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 197. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 198. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 199. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. GERMANY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 206. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 207. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 208. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 209. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 210. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 211. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 212. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 213. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. FRANCE HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 234. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 235. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 236. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 237. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 240. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 241. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 242. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 243. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ITALY HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 248. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 249. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 250. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 251. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 252. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 253. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 254. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 255. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 256. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 257. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. SPAIN HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA HUMAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA HUMAN MICROBIOME SEQUENCING SERVICES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Microbiome Sequencing Services Market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific SE
  • bioMérieux S.A.
  • Azenta, Inc.
  • Novogene Co., Ltd.
  • CosmosID, Inc.
  • Microba Life Sciences Pty Ltd

Related Topics

Related Reports

Human Microbiome Market by Product Type (Fecal Microbiota Transplant, Microbiome Sequencing Services, Postbiotics), Indication (Gastrointestinal Disorders, Infections, Metabolic Disorders), Application, End User - Global Forecast 2025-2030 - Product Image

Human Microbiome Market by Product Type (Fecal Microbiota Transplant, Microbiome Sequencing Services, Postbiotics), Indication (Gastrointestinal Disorders, Infections, Metabolic Disorders), Application, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Microbiome Sequencing Services Market by Sample Type (Fecal, Oral, Skin), Technology (Amplicon Sequencing, Metatranscriptomic Sequencing, Shotgun Metagenomic Sequencing), Application, End User - Global Forecast 2025-2030 - Product Image

Microbiome Sequencing Services Market by Sample Type (Fecal, Oral, Skin), Technology (Amplicon Sequencing, Metatranscriptomic Sequencing, Shotgun Metagenomic Sequencing), Application, End User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Forecast to 2028 - Product Image

Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Forecast to 2028

  • Report
  • 179 Pages
  • Global
From
Microbiome Diagnostics - Global Strategic Business Report - Product Image

Microbiome Diagnostics - Global Strategic Business Report

  • Report
  • 569 Pages
  • Global
From
Cancer Microbiome Sequencing Market by Technology (16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole Genome Sequencing), Application (Breast Cancer, Colorectal Cancer, Lung Cancer), Workflow, End User, Sample Type - Global Forecast 2025-2030 - Product Image

Cancer Microbiome Sequencing Market by Technology (16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole Genome Sequencing), Application (Breast Cancer, Colorectal Cancer, Lung Cancer), Workflow, End User, Sample Type - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.